Prostate Cancer Metastatic

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

FTT PET/CT in Metastatic Prostate Cancer

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Castrate Resistant Prostate Cancer Enhertu Therapy

Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)